[go: up one dir, main page]

GB791281A - Pharmaceutical products - Google Patents

Pharmaceutical products

Info

Publication number
GB791281A
GB791281A GB1036/55A GB103655A GB791281A GB 791281 A GB791281 A GB 791281A GB 1036/55 A GB1036/55 A GB 1036/55A GB 103655 A GB103655 A GB 103655A GB 791281 A GB791281 A GB 791281A
Authority
GB
United Kingdom
Prior art keywords
tablets
resins
starch
cation exchange
exchange resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1036/55A
Inventor
Arnold Richard Webster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Pharmaceuticals Ltd
Original Assignee
Genatosan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genatosan Ltd filed Critical Genatosan Ltd
Priority to GB1036/55A priority Critical patent/GB791281A/en
Publication of GB791281A publication Critical patent/GB791281A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tablets, granules and other bodies of compressed powdery material for pharmaceutical use and food products such as cubes of meat extract include from 0.5 to 15 per cent of their total weight of a cation exchange resin not containing silver ions. Preferably the resin is of particle size not less than about 30 B.S. mesh. Specified resins include carboxylic resins, sulphonated polyamine, phenolic, polystyrene and amine resins. They may be used in the acid or salt (sodium, potassium or ammonium) form as desired. Conventional additives such as starch, lubricants and wetting agents may also be incorporated in the tablets. In an example, a mixture of phenobarbitone, lactose, starch and gelatin is granulated and formed into tablets using magnesium stearate as lubricant and a carboxylic cation exchange resin such as that sold under the Registered Trade Mark "Amberlite" XE-88.
GB1036/55A 1955-01-13 1955-01-13 Pharmaceutical products Expired GB791281A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1036/55A GB791281A (en) 1955-01-13 1955-01-13 Pharmaceutical products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1036/55A GB791281A (en) 1955-01-13 1955-01-13 Pharmaceutical products

Publications (1)

Publication Number Publication Date
GB791281A true GB791281A (en) 1958-02-26

Family

ID=9715025

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1036/55A Expired GB791281A (en) 1955-01-13 1955-01-13 Pharmaceutical products

Country Status (1)

Country Link
GB (1) GB791281A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091574A (en) * 1961-09-05 1963-05-28 Bristol Myers Co Tablet disintegrants
US3297530A (en) * 1958-12-23 1967-01-10 Ici Ltd Antidepressant compositions and methods of using same
EP0368682B1 (en) * 1988-11-11 1995-05-31 Euroceltique S.A. Pharmaceutical ion exchange resin composition
US5637308A (en) * 1995-07-10 1997-06-10 Buckman Laboratories International, Inc. Tabletized ionene polymers
US5707534A (en) * 1995-07-10 1998-01-13 Buckman Laboratories International, Inc. Use of tabletized ionene polymers in water treatment
US5709880A (en) * 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297530A (en) * 1958-12-23 1967-01-10 Ici Ltd Antidepressant compositions and methods of using same
US3091574A (en) * 1961-09-05 1963-05-28 Bristol Myers Co Tablet disintegrants
EP0368682B1 (en) * 1988-11-11 1995-05-31 Euroceltique S.A. Pharmaceutical ion exchange resin composition
US5637308A (en) * 1995-07-10 1997-06-10 Buckman Laboratories International, Inc. Tabletized ionene polymers
US5707534A (en) * 1995-07-10 1998-01-13 Buckman Laboratories International, Inc. Use of tabletized ionene polymers in water treatment
US5709880A (en) * 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers

Similar Documents

Publication Publication Date Title
US2985562A (en) Effervescent compositions
ES312728A1 (en) Procedure for the preparation of compresses by compression of dust mixtures. (Machine-translation by Google Translate, not legally binding)
GB791281A (en) Pharmaceutical products
IE35913B1 (en) Animal feedstuff
JPS5572117A (en) Analgesic tablet and its manufacture
ES399609A1 (en) Preparation of an acidified milk product in powder form
ES304084A1 (en) A procedure for the production of compositions to combat gastro-intestinal parasites in animals. (Machine-translation by Google Translate, not legally binding)
SE305509B (en)
US4028239A (en) Process for preventing lime deposits in a humidifier
GB1499672A (en) Tablet formulation
ES416160A1 (en) Process for the preparation of an additive for maize silage on the basis of prilled urea
ES372048A1 (en) Improved procedure for the obtaining of extinguishing compositions based on monoamonic orthophosphate. (Machine-translation by Google Translate, not legally binding)
US2603566A (en) Salt composition and method of producing the same
GB844445A (en) Dry fire-extinguishing powders
GB1014701A (en) Salt composition useful in processing meat and method of producing the same
GB833744A (en) Treatment of boiler feed water
GB1227042A (en)
ES217349A1 (en) A procedure for the obtaining of a pure mass fosfate and potass salts (Machine-translation by Google Translate, not legally binding)
DE3260619D1 (en) An efficiency-improving agent for feed and a preventive and treating agent for coccidiosis
GB898867A (en) Co moulding sand
GB590725A (en) Improvements in or relating to the production of tablets, pellets or briquettes
GB812146A (en) Improvements relating to fire extinguishing agents
GB727870A (en) Derivatives of sym-triacetylbenzene
JPS5236618A (en) Process for preparation of granular solbic acid
GB817001A (en) Improvements in or relating to diazonium compounds